These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 30819688

  • 1. Prospective randomised clinical trial of intravitreal bevacizumab versus triamcinolone in eyes with diabetic macular oedema undergoing cataract surgery: 6-month results.
    Kandasamy R, Constantinou M, Rogers SL, Sandhu SS, Wickremasinghe S, Al-Qureshi S, Lim LL.
    Br J Ophthalmol; 2019 Dec; 103(12):1753-1758. PubMed ID: 30819688
    [Abstract] [Full Text] [Related]

  • 2. Diabetic Macular Edema at the time of Cataract Surgery trial: a prospective, randomized clinical trial of intravitreous bevacizumab versus triamcinolone in patients with diabetic macular oedema at the time of cataract surgery - preliminary 6 month results.
    Lim LL, Morrison JL, Constantinou M, Rogers S, Sandhu SS, Wickremasinghe SS, Kawasaki R, Al-Qureshi S.
    Clin Exp Ophthalmol; 2016 May; 44(4):233-42. PubMed ID: 26871700
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
    Sheth S, Rush R, Natarajan S, Gillies M.
    Clin Exp Ophthalmol; 2011 May; 39(7):673-81. PubMed ID: 22452685
    [Abstract] [Full Text] [Related]

  • 4. Response of Retinal Sensitivity to Intravitreal Anti-angiogenic Bevacizumab and Triamcinolone Acetonide for Patients with Diabetic Macular Edema over One Year.
    Mylonas G, Schranz M, Scholda C, Karst S, Reiter G, Baumann L, Schmidt-Erfurth U, Kriechbaum K.
    Curr Eye Res; 2020 Sep; 45(9):1107-1113. PubMed ID: 31961224
    [Abstract] [Full Text] [Related]

  • 5. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract.
    Akinci A, Muftuoglu O, Altınsoy A, Ozkılıc E.
    Retina; 2011 Apr; 31(4):755-8. PubMed ID: 21124251
    [Abstract] [Full Text] [Related]

  • 6. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
    Mehta H, Hennings C, Gillies MC, Nguyen V, Campain A, Fraser-Bell S.
    Cochrane Database Syst Rev; 2018 Apr 18; 4(4):CD011599. PubMed ID: 29669176
    [Abstract] [Full Text] [Related]

  • 7. Diabetic retinopathy progression 6 months post-cataract surgery with intravitreous bevacizumab vs triamcinolone: A secondary analysis of the DiMECAT trial.
    Sasongko MB, Rogers S, Constantinou M, Sandhu SS, Wickremasinghe SS, Al-Qureshi S, Lim LL.
    Clin Exp Ophthalmol; 2020 Aug 18; 48(6):793-801. PubMed ID: 32356581
    [Abstract] [Full Text] [Related]

  • 8. Comparing intravitreal triamcinolone acetonide and bevacizumab injections for the treatment of diabetic macular oedema: a randomized double-blind study.
    Isaac DL, Abud MB, Frantz KA, Rassi AR, Avila M.
    Acta Ophthalmol; 2012 Feb 18; 90(1):56-60. PubMed ID: 20015098
    [Abstract] [Full Text] [Related]

  • 9. Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema.
    Faghihi H, Roohipoor R, Mohammadi SF, Hojat-Jalali K, Mirshahi A, Lashay A, Piri N, Faghihi Sh.
    Eur J Ophthalmol; 2008 Feb 18; 18(6):941-8. PubMed ID: 18988166
    [Abstract] [Full Text] [Related]

  • 10. Intravitreal bevacizumab (Avastin) versus triamcinolone (Volon A) for treatment of diabetic macular edema: one-year results.
    Kriechbaum K, Prager S, Mylonas G, Scholda C, Rainer G, Funk M, Kundi M, Schmidt-Erfurth U, Diabetic Retinopathy Research Group.
    Eye (Lond); 2014 Jan 18; 28(1):9-15; quiz 16. PubMed ID: 24336297
    [Abstract] [Full Text] [Related]

  • 11. Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections.
    Shin YU, Hong EH, Lim HW, Kang MH, Seong M, Cho H.
    BMC Ophthalmol; 2017 Oct 03; 17(1):182. PubMed ID: 28974211
    [Abstract] [Full Text] [Related]

  • 12. Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).
    Paccola L, Costa RA, Folgosa MS, Barbosa JC, Scott IU, Jorge R.
    Br J Ophthalmol; 2008 Jan 03; 92(1):76-80. PubMed ID: 17965109
    [Abstract] [Full Text] [Related]

  • 13. Analysis of the effect of intravitreal bevacizumab injection on diabetic macular edema after cataract surgery.
    Takamura Y, Kubo E, Akagi Y.
    Ophthalmology; 2009 Jun 03; 116(6):1151-7. PubMed ID: 19376589
    [Abstract] [Full Text] [Related]

  • 14. Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial.
    Ahmadieh H, Ramezani A, Shoeibi N, Bijanzadeh B, Tabatabaei A, Azarmina M, Soheilian M, Keshavarzi G, Mohebbi MR.
    Graefes Arch Clin Exp Ophthalmol; 2008 Apr 03; 246(4):483-9. PubMed ID: 17917738
    [Abstract] [Full Text] [Related]

  • 15. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
    Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H, Zhu M.
    Ophthalmology; 2006 Sep 03; 113(9):1533-8. PubMed ID: 16828501
    [Abstract] [Full Text] [Related]

  • 16. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X, Li J, Hu X, Yu S, Pan J, Tang S.
    Retina; 2011 May 03; 31(5):838-45. PubMed ID: 21293319
    [Abstract] [Full Text] [Related]

  • 17. Effect of intravitreal triamcinolone in diabetic macular edema unresponsive to intravitreal bevacizumab.
    Jeon S, Lee WK.
    Retina; 2014 Aug 03; 34(8):1606-11. PubMed ID: 24553409
    [Abstract] [Full Text] [Related]

  • 18. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
    Soheilian M, Ramezani A, Obudi A, Bijanzadeh B, Salehipour M, Yaseri M, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S, Peyman GA.
    Ophthalmology; 2009 Jun 03; 116(6):1142-50. PubMed ID: 19376585
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of intravitreal anti-vascular endothelial growth factor or steroid injection in diabetic macular edema according to fluid turbidity in optical coherence tomography.
    Lee K, Chung H, Park Y, Sohn J.
    Korean J Ophthalmol; 2014 Aug 03; 28(4):298-305. PubMed ID: 25120338
    [Abstract] [Full Text] [Related]

  • 20. Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema.
    Liu Q, Hu Y, Yu H, Yuan L, Hu J, Atik A, Guan M, Li D, Li X, Tang S.
    Retina; 2015 Feb 03; 35(2):272-9. PubMed ID: 25105313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.